Security key
641288105
NeuroPace Inc - Common Stock, $0.01 par value (NPCE)
CUSIP: 641288105
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 26,299,826
- Total 13F value
- $405,917,159
- Share change
- +706,379
- SEC-reported price per share
- $15.44
- Number of holders
- 100
- Value change
- +$12,534,292
- Number of buys
- 61
- Number of sells
- 34
- Shares outstanding
- 34,087,924
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
100
Top holders
10
NPCE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
NeuroPace Inc SEC filings
NeuroPace Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 641288105
Recent filing periods:
Ownership snapshot
Top reported holders of NPCE - NeuroPace Inc - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Polar Capital Holdings Plc
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
3/4/5
Lead comparable stake: 9.1%
13D/G row: Polar Capital Holdings Plc
Showing 1-6 of 15 holder rows.
Quick read
Polar Capital Holdings Plc leads the comparable SEC ownership view at 9.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Polar Capital Holdings Plc's linked filing trail.
Comparable ownership
Top 5
Polar Capital Holdings Plc
9.1%
Soleus Private Equity Fund I, L.P.
8.9%
MORGAN STANLEY
8.3%
Soleus Capital Master Fund, L.P.
7%
Kent Lake PR LLC
4.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Polar Capital Holdings Plc |
13D/G
13F
Company
|
9.1%
|
$34,534,675
2,972,003 shares
|
$0 | 31 Mar 2025 |
| Soleus Private Equity Fund I, L.P. |
13D/G
Guy Levy
|
8.9%
|
$30,496,537
2,957,957 shares
|
$0 | 30 Sep 2025 |
| MORGAN STANLEY |
13D/G
13F
Company
|
8.3%
|
$28,926,723
2,489,391 shares
|
$0 | 31 Dec 2024 |
| Soleus Capital Master Fund, L.P. |
13D/G
Soleus Capital Management, L.P.
|
7%
|
$23,545,122
2,303,828 shares
|
$0 | 30 Jun 2025 |
| Kent Lake PR LLC |
13D/G
13F
Company
|
4.9%
|
$17,227,289
1,482,555 shares
|
+$116,944 | 31 Dec 2024 |
| ORBIMED ADVISORS LLC |
3/4/5
13F
10%+ Owner · Company
|
9.5%
|
$51,616,892
3,238,199 shares
|
— | 14 May 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
100
Shares
26,299,826
Rows available
100
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
80
Q4 2025 holders
100
Holder diff
20
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend